Production of the monoclonal antibody Trastuzumab in Komagataella phaffii (Pichia pastoris) for breast cancer treatment
OverviewProgramme: Bioindustry 4.0
SEEK ID: https://ibisbahub.eu/projects/89
Public web page: Not specified
Organisms: No Organisms specified
IBISBA PALs: No PALs for this Project
Project created: 20th Oct 2025
TagsThis item has not yet been tagged.
Related items
Projects: Scorpion antivenom nanobody production in Escherichia coli (Recombinant bispecific VHH), Production of the monoclonal antibody Trastuzumab in Komagataella phaffii (Pichia pastoris) for breast cancer treatment
Institutions: INSAT - Institut National des Science Appliquees de Toulouse, INRAE
https://orcid.org/0000-0001-8290-1635
Bioprocess engineer with extensive expertise in bioreactor process design, fermentation technologies, and protein production. Skilled in scaling up bioprocesses, experimental design, and process optimization.
Responsible of the Transnational Access of IBISBA1.0
Research Director at INRA Director Life Sciences at Toulouse White Biotechnology
Bioindustry 4.0 is a cutting-edge initiative perfecting advanced technologies to empower European bioindustry sector. Our overarching aim is to make the development of bioprocesses faster and cheaper, and biomanufacturing more reliable.
Projects: Scorpion antivenom nanobody production in Escherichia coli (Recombinant bispecific VHH), Production of the monoclonal antibody Trastuzumab in Komagataella phaffii (Pichia pastoris) for breast cancer treatment
Web page: https://www.bioindustry4.eu
